173 related articles for article (PubMed ID: 12859967)
41. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA.
Valencia JV; Mone M; Zhang J; Weetall M; Buxton FP; Hughes TE
Diabetes; 2004 Mar; 53(3):743-51. PubMed ID: 14988260
[TBL] [Abstract][Full Text] [Related]
42. S100-mediated signal transduction in the nervous system and neurological diseases.
Zimmer DB; Chaplin J; Baldwin A; Rast M
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):201-14. PubMed ID: 16171556
[TBL] [Abstract][Full Text] [Related]
43. Structural and functional insights into RAGE activation by multimeric S100B.
Ostendorp T; Leclerc E; Galichet A; Koch M; Demling N; Weigle B; Heizmann CW; Kroneck PM; Fritz G
EMBO J; 2007 Aug; 26(16):3868-78. PubMed ID: 17660747
[TBL] [Abstract][Full Text] [Related]
44. Implication of the RAGE-EN-RAGE axis in endometriosis.
Sharma I; Dhawan V; Saha SC; Rashmi B; Dhaliwal LK
Int J Gynaecol Obstet; 2010 Sep; 110(3):199-202. PubMed ID: 20537326
[TBL] [Abstract][Full Text] [Related]
45. S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.
Villarreal A; Aviles Reyes RX; Angelo MF; Reines AG; Ramos AJ
J Neurochem; 2011 Apr; 117(2):321-32. PubMed ID: 21291473
[TBL] [Abstract][Full Text] [Related]
46. Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins.
Bronckart Y; Decaestecker C; Nagy N; Harper L; Schäfer BW; Salmon I; Pochet R; Kiss R; Heizman CW
Histol Histopathol; 2001 Jul; 16(3):707-12. PubMed ID: 11510959
[TBL] [Abstract][Full Text] [Related]
47. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products.
Yammani RR; Carlson CS; Bresnick AR; Loeser RF
Arthritis Rheum; 2006 Sep; 54(9):2901-11. PubMed ID: 16948116
[TBL] [Abstract][Full Text] [Related]
48. Measuring binding of S100 proteins to RAGE by surface plasmon resonance.
Leclerc E
Methods Mol Biol; 2013; 963():201-13. PubMed ID: 23296613
[TBL] [Abstract][Full Text] [Related]
49. Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells.
Haase-Kohn C; Wolf S; Lenk J; Pietzsch J
Biochem Biophys Res Commun; 2011 Sep; 413(3):494-8. PubMed ID: 21924240
[TBL] [Abstract][Full Text] [Related]
50. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
[TBL] [Abstract][Full Text] [Related]
51. S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation.
Tsoporis JN; Izhar S; Proteau G; Slaughter G; Parker TG
J Mol Cell Cardiol; 2012 Feb; 52(2):464-73. PubMed ID: 21889514
[TBL] [Abstract][Full Text] [Related]
52. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
Rani SG; Sepuru KM; Yu C
Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
[TBL] [Abstract][Full Text] [Related]
53. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
[TBL] [Abstract][Full Text] [Related]
54. RAGE and RAGE ligands in cancer.
Logsdon CD; Fuentes MK; Huang EH; Arumugam T
Curr Mol Med; 2007 Dec; 7(8):777-89. PubMed ID: 18331236
[TBL] [Abstract][Full Text] [Related]
55. Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling.
Kalea AZ; See F; Harja E; Arriero M; Schmidt AM; Hudson BI
Cancer Res; 2010 Jul; 70(13):5628-38. PubMed ID: 20570900
[TBL] [Abstract][Full Text] [Related]
56. Multiple structural states of S100A12: A key to its functional diversity.
Moroz OV; Dodson GG; Wilson KS; Lukanidin E; Bronstein IB
Microsc Res Tech; 2003 Apr; 60(6):581-92. PubMed ID: 12645006
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of S100 calcium-binding proteins in epidermoid cysts, branchial cysts, craniopharyngiomas and cholesteatomas.
Pelc P; Vanmuylder N; Lefranc F; Heizmann CW; Hassid S; Salmon I; Kiss R; Louryan S; Decaestecker C
Histopathology; 2003 Apr; 42(4):387-94. PubMed ID: 12653951
[TBL] [Abstract][Full Text] [Related]
58. Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction.
Fuellen G; Foell D; Nacken W; Sorg C; Kerkhoff C
Trends Immunol; 2003 Dec; 24(12):622-4. PubMed ID: 14644132
[No Abstract] [Full Text] [Related]
59. Extracellular S100A4 induces smooth muscle cell phenotypic transition mediated by RAGE.
Chaabane C; Heizmann CW; Bochaton-Piallat ML
Biochim Biophys Acta; 2015 Sep; 1853(9):2144-57. PubMed ID: 25110349
[TBL] [Abstract][Full Text] [Related]
60. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
